|
Morgan Stanley PLUS Basket of 2 Pharmaceutical Stocks due 6/30/2006
Ticker Symbol: DRP** CUSIP: 61746Y635 Exchange: AMEX
* NOTE: This security is no longer trading as of 6/30/2006
QUANTUMONLINE.COM SECURITY DESCRIPTION: Morgan Stanley PLUS (Performance Leveraged Upside Securities) due 6/30/2006, issued at $5.00 per PLUS, and linked to the value of a basket of 2 pharmaceutical stocks (Merck & Co. Inc. ($32.06) and Pfizer Inc. ($26.04). The PLUS notes pay no interest, are not callable prior to maturity and do not guarantee any return of principal at maturity. At maturity, if the basket value exceeds the initial value, the PLUS will pay a cash payment based on the final value of the two pharmaceutical industry stocks plus a supplemental amount equal to 300% of the amount that the stock's final values exceed the initial value, subject to a maximum payment of $5.8625 (117.25% of the issue price). If the final value of the basket at maturity is less than the initial value, the holder will receive a payment that is less, and possibily significantly less, than the issue price of the PLUS based on the proportional decrease in the basket. See page PS-4 of the prospectus for further information on the maturity payment. The PLUS are Global Medium-Term Notes, Series F, Senior Fixed Rate Notes which are senior unsecured debt securities issued by Morgan Stanley and will rank equally with all of their other unsecured and unsubordinated debt. See the IPO prospectus for further information on the PLUS notes and the maturity payment by clicking on the ‘Link to IPO Prospectus’ provided below.
|
Go to Parent Company's Record (MS)
IPO - 3/29/2005 - 1.30 Million Notes @ $5.00/note.
Link to IPO Prospectus
Market Value $6.5 Million
Company's Online Information Links
|
Company's Online SEC EDGAR Filings |
Company's Email Address Links |
Address and Phone Numbers |
Address: 1585 Broadway, New York, NY 10036 |
Main Phone Number |
212-761-4000 |
Fax Number |
212-761-0086 |
Investor Contact
William Pike
|
212-761-0008
|
Toll Free Phone Number |
800-733-2307 |
CEO - Philip J. Purcell |
CFO - Robert Scott |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|